Prescription Drug Monitoring Programs

"Prescription Drug Monitoring Programs" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Programs, usually run by state governments, that require pharmacists to collect and distribute data on the prescription and dispensation of CONTROLLED SUBSTANCES. They are intended to prevent the abuse of such substances by the patient, or their transfer to recreational users and drug dealers.

Descriptor ID	D000073958
MeSH Number(s)	E05.337.800.800 N02.421.668.320.600
Concept/Terms	Prescription Drug Monitoring Programs Prescription Drug Monitoring Programs Prescription Monitoring Monitoring, Prescription Prescription Monitorings Prescription Drug Monitoring Program

Below are MeSH descriptors whose meaning is more general than "Prescription Drug Monitoring Programs".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Investigative Techniques [E05]
Evaluation Studies as Topic [E05.337]
Product Surveillance, Postmarketing [E05.337.800]
Prescription Drug Monitoring Programs [E05.337.800.800]
Health Care [N]
Health Care Facilities, Manpower, and Services [N02]
Health Services [N02.421]
Pharmaceutical Services [N02.421.668]
Drug Information Services [N02.421.668.320]
Prescription Drug Monitoring Programs [N02.421.668.320.600]

Below are MeSH descriptors whose meaning is related to "Prescription Drug Monitoring Programs".

Below are MeSH descriptors whose meaning is more specific than "Prescription Drug Monitoring Programs".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Prescription Drug Monitoring Programs" by people in this website by year, and whether "Prescription Drug Monitoring Programs" was a major or minor topic of these publications.

Bar chart showing 8 publications over 6 distinct years, with a maximum of 2 publications in 2020 and 2022

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2019	1	0	1
2020	2	0	2
2021	1	0	1
2022	2	0	2
2023	1	0	1
2024	0	1	1

Below are the most recent publications written about "Prescription Drug Monitoring Programs" by people in Profiles.

Trenchfield D, Fras S, McCurdy M, Narayanan R, Lee Y, Issa T, Toci G, Oghli Y, Siddiqui H, Vo M, Mahmood H, Schilken M, Pashaee B, Mangan J, Kurd M, Kaye ID, Canseco JA, Hilibrand AS, Vaccaro AR, Kepler CK, Schroeder GD. Opioid Prescription Trends Among Orthopaedic, Primary Care, and Pain Management Providers in Spine Surgery Patients. J Am Acad Orthop Surg. 2024 Dec 01; 32(23):e1252-e1259.

View in: PubMed
Adalbert JR, Syal A, Varshney K, George B, Hom J, Ilyas AM. The prescription drug monitoring program in a multifactorial approach to the opioid crisis: PDMP data, Pennsylvania, 2016-2020. BMC Health Serv Res. 2023 Apr 13; 23(1):364.

View in: PubMed
Siegel N, Lambrechts MJ, Minetos P, Karamian BA, Nourie B, Curran J, Wang J, Canseco JA, Woods BI, Kaye D, Hilibrand AS, Kepler CK, Vaccaro AR, Schroeder GD. The Effect of Online Prescription Drug Monitoring on Opioid Prescription Habits After Elective Single-level Lumbar Fusion. J Am Acad Orthop Surg. 2022 11 01; 30(21):e1411-e1418.

View in: PubMed
Zavodnick J, Wickersham A, Petok A, Worster B, Leader A. "1,000 conversations I'd rather have than that one:" A qualitative study of prescriber experiences with opioids and the impact of a prescription drug monitoring program. J Addict Dis. 2022 Oct-Dec; 40(4):527-537.

View in: PubMed
Karamian BA, Jeyamohan H, Minetos PD, Kothari P, Canseco JA, Bowles DR, Pekuri A, Conaway W, DiMaria SL, Mao JZ, Woods BI, Kaye ID, Lee JK, Rihn JA, Hilibrand AS, Kepler CK, Vaccaro AR, Schroeder GD. Effect of a Mandatory Prescription Drug Monitoring Program on Patient-initiated Phone Calls After Spine Surgery. Clin Spine Surg. 2022 06 01; 35(5):E405-E411.

View in: PubMed
Tan TL, Rondon AJ, Wilt Z, Wang WL, Kalbian I, Foltz C, Beredjiklian PK, Arnold WV. Understanding Opioid Use After Total Hip Arthroplasty: A Comprehensive Analysis of a Mandatory Prescription Drug Monitoring Program. J Am Acad Orthop Surg. 2020 Oct 15; 28(20):e917-e922.

View in: PubMed
Pizzicato LN, Hom JK, Sun M, Johnson CC, Viner KM. Adherence to buprenorphine: An analysis of prescription drug monitoring program data. Drug Alcohol Depend. 2020 11 01; 216:108317.

View in: PubMed
Hozack BA, Rivlin M, Graham J, Lutsky KF, Beredjiklian PK. Validation of the prescription drug monitoring program Web site. J Opioid Manag. 2019 Nov/Dec; 15(6):495-498.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement